BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29463546)

  • 1. Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice.
    de Paula TP; Santos PC; Arifa RDDN; Vieira AT; Baltazar LM; Ávila TV; Fagundes CT; Garcia ZM; Lima RL; Teixeira MM; Souza DG
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.
    Hilliard JJ; Melton JL; Hall L; Abbanat D; Fernandez J; Ward CK; Bunting RA; Barron A; Lynch AS; Flamm RK
    Antimicrob Agents Chemother; 2011 Feb; 55(2):836-44. PubMed ID: 21135187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with andrographolide sulfonate provides additional benefits to imipenem in a mouse model of Klebsiella pneumoniae pneumonia.
    Zhang G; Jiang C; Xie N; Xu Y; Liu L; Liu N
    Biomed Pharmacother; 2019 Sep; 117():109065. PubMed ID: 31220744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
    Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
    Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
    Pichardo C; Rodríguez-Martínez JM; Pachón-Ibañez ME; Conejo C; Ibáñez-Martínez J; Martínez-Martínez L; Pachón J; Pascual A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3311-6. PubMed ID: 16048941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effect of thalidomide alone or in combination with augmentin in Klebsiella pneumoniae B5055 induced acute lung infection in BALB/c mice.
    Kumar V; Chhibber S
    Eur J Pharmacol; 2008 Sep; 592(1-3):146-50. PubMed ID: 18662682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae.
    Holloway AJ; Yu J; Arulanandam BP; Hoskinson SM; Eaves-Pyles T
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features and antimicrobial resistance of community-acquired pneumonia caused by Klebsiella pneumoniae in infants].
    He LY; Wang YJ; Li JM
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Nov; 14(11):827-9. PubMed ID: 23146728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin alone and in combination with augmentin protects against pulmonary inflammation and acute lung injury generated during Klebsiella pneumoniae B5055-induced lung infection in BALB/c mice.
    Bansal S; Chhibber S
    J Med Microbiol; 2010 Apr; 59(Pt 4):429-437. PubMed ID: 20056776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.
    Wu G; Wu P; Xue X; Yan X; Liu S; Zhang C; Shen Z; Xi T
    Peptides; 2013 Jul; 45():73-7. PubMed ID: 23643614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Hirsch EB; Guo B; Chang KT; Cao H; Ledesma KR; Singh M; Tam VH
    J Infect Dis; 2013 Mar; 207(5):786-93. PubMed ID: 23242537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Chloroadenosine (2-CADO) treatment modulates the pro-inflammatory immune response to prevent acute lung inflammation in BALB/c mice suffering from Klebsiella pneumoniae B5055-induced pneumonia.
    Kumar V; Harjai K; Chhibber S
    Int J Antimicrob Agents; 2010 Jun; 35(6):599-602. PubMed ID: 20189776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
    Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Máthé A; Szabó D; Anderlik P; Rozgonyi F; Nagy K
    Diagn Microbiol Infect Dis; 2007 May; 58(1):105-10. PubMed ID: 17300908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Therapeutic Treatment with the GAG-Binding Chemokine Fragment CXCL9(74-103) Attenuates Neutrophilic Inflammation and Lung Dysfunction during
    Boff D; Russo RC; Crijns H; de Oliveira VLS; Mattos MS; Marques PE; Menezes GB; Vieira AT; Teixeira MM; Proost P; Amaral FA
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682923
    [No Abstract]   [Full Text] [Related]  

  • 18. Klebsiella pneumoniae Siderophores Induce Inflammation, Bacterial Dissemination, and HIF-1α Stabilization during Pneumonia.
    Holden VI; Breen P; Houle S; Dozois CM; Bachman MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27624128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
    Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
    Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-mobility group nucleosome-binding domain 2 protein inhibits the invasion of Klebsiella pneumoniae into mouse lungs in vivo.
    Zheng S; Ren L; Li H; Shen X; Yang X; Li N; Wang X; Guo X; Wang X; Huang N
    Mol Med Rep; 2015 Jul; 12(1):1279-85. PubMed ID: 25760831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.